HPC HOLDINGS (01742) Announces Profit Growth, Expected Mid-term Net Profit Approximately 9.34 Million Singapore Dollars.
HPC Holdings (01742) announced that the group expects to have an unaudited net profit of approximately 9.34 million new dollars for the six-month period ended April 30, 2026, while the net profit for the six-month period ended April 30, 2025 was approximately 31.34 million new dollars.
HPC Holdings (01742) announced that the group expects unaudited net profit for the half-year ending on April 30, 2026 to be around 9.34 million new yuan, while the net profit for the half-year ending on April 30, 2025 was approximately 31.34 million new yuan.
The Board of Directors would like to emphasize to shareholders that as stated in the previous year's interim and annual reports, the net profit for the previous year included a one-time gain of about 27.58 million new yuan from a bargain purchase, which was not from operational income. Excluding this gain, the group's net profit increased by approximately 5.58 million new yuan, a growth of about 148% compared to the previous period. The significant improvement in the performance of the core business operations mentioned above is mainly attributed to the implementation of strong orders accumulated in the previous year and more projects under construction entering a peak period, leading to an increase in construction activity compared to the previous period.
Related Articles

HK Stock Market Move | INSILICO (03696) rose nearly 8% in the afternoon, reaching a cooperation agreement with SK Biopharmaceuticals in the field of AI-driven research and development in neuroimmunology diseases.

NISSIN FOODS(01475): Nissin Japan's annual profit of 6.783 billion yen increased by 75.23% year-on-year.

INSILICO (03696) has reached a high-value AI-driven research and development collaboration in the field of neuroimmunology diseases with SK Biopharmaceuticals worth up to 2.5 billion USD.
HK Stock Market Move | INSILICO (03696) rose nearly 8% in the afternoon, reaching a cooperation agreement with SK Biopharmaceuticals in the field of AI-driven research and development in neuroimmunology diseases.

NISSIN FOODS(01475): Nissin Japan's annual profit of 6.783 billion yen increased by 75.23% year-on-year.

INSILICO (03696) has reached a high-value AI-driven research and development collaboration in the field of neuroimmunology diseases with SK Biopharmaceuticals worth up to 2.5 billion USD.

RECOMMEND





